000 01182 a2200337 4500
005 20250514000126.0
264 0 _c20010517
008 200105s 0 0 eng d
022 _a0735-7907
024 7 _a10.1081/cnv-100102556
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPastore, R D
245 0 0 _aRenal cell carcinoma and interferon at the millennium.
_h[electronic resource]
260 _bCancer investigation
_c2001
300 _a281-91 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aCarcinoma, Renal Cell
_xdrug therapy
650 0 4 _aCombined Modality Therapy
650 0 4 _aHumans
650 0 4 _aInterferon-alpha
_xpharmacology
650 0 4 _aInterferon-gamma
_xpharmacology
650 0 4 _aInterleukin-2
_xtherapeutic use
650 0 4 _aKidney Neoplasms
_xdrug therapy
650 0 4 _aProtein-Tyrosine Kinases
_xmetabolism
650 0 4 _aSignal Transduction
700 1 _aPfeffer, L M
700 1 _aNanus, D M
773 0 _tCancer investigation
_gvol. 19
_gno. 3
_gp. 281-91
856 4 0 _uhttps://doi.org/10.1081/cnv-100102556
_zAvailable from publisher's website
999 _c11271909
_d11271909